Evidence map›Paper›PMID 35401954›Full record

ArticleFrontline gastroenterology2021

Characteristics and attitudes of first round invitees in the Irish National Colorectal Cancer Screening Programme.

Susanne M O'Reilly, Katie N Hughes, Therese Mooney, Patricia Fitzpatrick, Diarmuid O'Donoghue, Sara McNally, Mary Codd, Elizabeth Ryan, Glen Doherty, Olivia Mason and 2 more

Open access · greenAbstract read
In one paragraph

Article in Frontline gastroenterology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Susanne M O'ReillyCentre for Colorectal Disease, St Vincent's University Hospital, Dublin, Ireland.ORCID 0000-0002-9220-6465
Katie N HughesCentre for Colorectal Disease, St Vincent's University Hospital, Dublin, Ireland.
Therese MooneyBowelScreen, National Screening Service, Dublin, Ireland.
Patricia FitzpatrickBowelScreen, National Screening Service, Dublin, Ireland.
Diarmuid O'DonoghueCentre for Colorectal Disease, St Vincent's University Hospital, Dublin, Ireland.
Sara McNallyBowelScreen, National Screening Service, Dublin, Ireland.
Mary CoddSchool of Public Health, University College Dublin, Dublin, Ireland.
Elizabeth RyanCentre for Colorectal Disease, St Vincent's University Hospital, Dublin, Ireland.
Glen DohertyCentre for Colorectal Disease, St Vincent's University Hospital, Dublin, Ireland.
Olivia MasonSchool of Public Health, University College Dublin, Dublin, Ireland.
Hugh E MulcahyCentre for Colorectal Disease, St Vincent's University Hospital, Dublin, Ireland.
Garret CullenCentre for Colorectal Disease, St Vincent's University Hospital, Dublin, Ireland.
St. Vincent's University Hospital · IEUniversity College Dublin · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/objective: Colorectal cancer (CRC) screening is proven to reduce CRC-related mortality. Faecal immunochemical testing (FIT)-positive clients in the Irish National CRC Screening Programme underwent colonoscopy. Round 1 uptake was 40.2%. We sought to identify barriers to participation by assessing knowledge of CRC screening and examining attitudes towards FIT test and colonoscopy. Methods: Questionnaires based on a modified Champion's Health Belief Model were mailed to 3500 invitees: 1000 FIT-positive, 1000 FIT-negative and 1500 non-participants. 44% responded: 550 (46%) FIT-positive, 577 (48%) FIT-negative and 69 (6%) non-responders (NR). Results: 25% of respondents (n=286) did not perceive a personal risk of cancer, did not perceive CRC to be a serious disease and did not perceive benefits to screening. These opinions were more likely to be expressed by men (p=0.035). One-fifth (n=251) found screening stressful. Fear of cancer diagnosis and test results were associated with stress. FIT-positive clients, women and those with social medical insurance were more likely to experience stress. Conclusions: The CRC screening process causes stress to one-fifth of participants. Greater use of media and involvement of healthcare professionals in disseminating information on the benefits of screening may lead to higher uptake in round 2.

Indexed as

colorectal cancercolorectal cancer screeningscreening

Identifiers

PMID35401954
PMCPMC8989011
OpenAlexW3035629620

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.